Contact this trialFirst, we need to learn more about you.
SGLT2 Inhibitor
Empagliflozin for Kidney Transplant Complications
Recruiting0 awardsPhase 2
Durham, North Carolina
This trial is testing a diabetes medication in people who have had a kidney transplant. Half the patients have diabetes and half don't. The patients will be given either the medication or a placebo and monitored to see if the medication improves outcomes.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.